Skip to main content
Premium Trial:

Request an Annual Quote

Biomatters, GenomeQuest to Integrate Next-gen Sequencing Informatics Platforms

NEW YORK (GenomeWeb News) – The life sciences software developers Biomatters and GenomeQuest will integrate their analysis and data mining products for use in next-generation sequencing research projects, Biomatters said today.

Under the partnership, the companies will integrate Biomatters' Geneious Pro analysis and visualization software with GenomeQuest's 6.0Beta platform, which is used to manage and mine sequence data.

The resulting product will be used for global mining in next-gen sequencing projects to identify genomic areas of interest, perform investigations, and to manage sequence data, Auckland, New Zealand-based Biomatters said.

Biomatters CEO Candace Toner said in a statement that the software will provide researchers with "centralized data and access to common workflow solutions from discovery phase, through to complex analysis and publication."

The companies plan a technical launch of the integrated product service in October.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.